These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38498883)

  • 1. Exploring rhodanine linked enamine-carbohydrazide derivatives as mycobacterial carbonic anhydrase inhibitors: Design, synthesis, biological evaluation, and molecular docking studies.
    Maddipatla S; Bakchi B; Gadhave RR; Ammara A; Sau S; Rani B; Nanduri S; Kalia NP; Supuran CT; Yaddanapudi VM
    Arch Pharm (Weinheim); 2024 Jul; 357(7):e2400064. PubMed ID: 38498883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and structure-activity studies of new rhodanine derivatives as carbonic anhydrase II, IX inhibitors.
    Chinchilli KK; Akunuri R; Ghouse SM; Soujanya D; Angeli A; Parupalli R; Arifuddin M; Yaddanapudi VM; Supuran CT; Nanduri S
    Arch Pharm (Weinheim); 2023 Sep; 356(9):e2300205. PubMed ID: 37391391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The green synthesis and molecular docking of novel N-substituted rhodanines as effective inhibitors for carbonic anhydrase and acetylcholinesterase enzymes.
    Bayindir S; Caglayan C; Karaman M; Gülcin İ
    Bioorg Chem; 2019 Sep; 90():103096. PubMed ID: 31284100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploration of 3-aryl pyrazole-tethered sulfamoyl carboxamides as carbonic anhydrase inhibitors.
    Ommi O; Paoletti N; Bonardi A; Gratteri P; Bhalerao HA; Sau S; Nanduri S; Mohammed A; Kalia NP; Sonti R; Supuran CT; Yaddanapudi VM
    Arch Pharm (Weinheim); 2023 Nov; 356(11):e2300309. PubMed ID: 37691073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New thiopyrimidine-benzenesulfonamide conjugates as selective carbonic anhydrase II inhibitors: synthesis, in vitro biological evaluation, and molecular docking studies.
    Abdel-Mohsen HT; El Kerdawy AM; Omar MA; Berrino E; Abdelsamie AS; El Diwani HI; Supuran CT
    Bioorg Med Chem; 2020 Mar; 28(5):115329. PubMed ID: 32007388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, biological evaluation and molecular docking of novel pyrazole derivatives as potent carbonic anhydrase and acetylcholinesterase inhibitors.
    Turkan F; Cetin A; Taslimi P; Karaman M; Gulçin İ
    Bioorg Chem; 2019 May; 86():420-427. PubMed ID: 30769267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appliance of the piperidinyl-hydrazidoureido linker to benzenesulfonamide compounds: Synthesis, in vitro and in silico evaluation of potent carbonic anhydrase II, IX and XII inhibitors.
    Moi D; Nocentini A; Deplano A; Osman SM; AlOthman ZA; Piras V; Balboni G; Supuran CT; Onnis V
    Bioorg Chem; 2020 May; 98():103728. PubMed ID: 32182519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of novel benzenesulfonamide containing 1,2,3-triazoles as potent human carbonic anhydrase isoforms I, II, IV and IX inhibitors.
    Kumar R; Vats L; Bua S; Supuran CT; Sharma PK
    Eur J Med Chem; 2018 Jul; 155():545-551. PubMed ID: 29909339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring new Probenecid-based carbonic anhydrase inhibitors: Synthesis, biological evaluation and docking studies.
    Mollica A; Costante R; Akdemir A; Carradori S; Stefanucci A; Macedonio G; Ceruso M; Supuran CT
    Bioorg Med Chem; 2015 Sep; 23(17):5311-8. PubMed ID: 26264840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential inhibitors of human carbonic anhydrase isozymes I and II: Design, synthesis and docking studies of new 1,3,4-thiadiazole derivatives.
    Altıntop MD; Sever B; Özdemir A; Kucukoglu K; Onem H; Nadaroglu H; Kaplancıklı ZA
    Bioorg Med Chem; 2017 Jul; 25(13):3547-3554. PubMed ID: 28511907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, Synthesis and Molecular Docking Study of Novel 3-Phenyl-β-Alanine-Based Oxadiazole Analogues as Potent Carbonic Anhydrase II Inhibitors.
    Rafiq K; Ur Rehman N; Halim SA; Khan M; Khan A; Al-Harrasi A
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and molecular modelling studies of some pyrazole derivatives as carbonic anhydrase inhibitors.
    Dizdaroglu Y; Albay C; Arslan T; Ece A; Turkoglu EA; Efe A; Senturk M; Supuran CT; Ekinci D
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):289-297. PubMed ID: 31797703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of sulphonamide derivatives acting as inhibitors of human carbonic anhydrase isoforms I, II and Mycobacterium tuberculosis β-class enzyme Rv3273.
    Wani TV; Bua S; Khude PS; Chowdhary AH; Supuran CT; Toraskar MP
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):962-971. PubMed ID: 29772937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, characterization, in vitro and in silico evaluation of novel imidazo[2,1-b][1,3,4]thiadiazoles as highly potent acetylcholinesterase and non-classical carbonic anhydrase inhibitors.
    Askin S; Tahtaci H; Türkeş C; Demir Y; Ece A; Akalın Çiftçi G; Beydemir Ş
    Bioorg Chem; 2021 Aug; 113():105009. PubMed ID: 34052739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological evaluation of N-(5-methyl-isoxazol-3-yl/1,3,4-thiadiazol-2-yl)-4-(3-substitutedphenylureido) benzenesulfonamides as human carbonic anhydrase isoenzymes I, II, VII and XII inhibitors.
    Mishra CB; Kumari S; Angeli A; Monti SM; Buonanno M; Prakash A; Tiwari M; Supuran CT
    J Enzyme Inhib Med Chem; 2016; 31(sup2):174-179. PubMed ID: 27314170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel carbohydrate-based sulfonamide derivatives as selective carbonic anhydrase II inhibitors: Synthesis, biological and molecular docking analysis.
    Hou Z; Cai Q; Cheng MS
    Bioorg Med Chem Lett; 2021 Nov; 51():128291. PubMed ID: 34324968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of novel pyridine-thiazolidinone derivatives as anticancer agents: Targeting human carbonic anhydrase IX.
    Ansari MF; Idrees D; Hassan MI; Ahmad K; Avecilla F; Azam A
    Eur J Med Chem; 2018 Jan; 144():544-556. PubMed ID: 29289880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel N-methyl carbazole tethered rhodanine derivatives as direct inhibitors of Mycobacterium tuberculosis InhA.
    Shaikh MS; Kanhed AM; Chandrasekaran B; Palkar MB; Agrawal N; Lherbet C; Hampannavar GA; Karpoormath R
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2338-2344. PubMed ID: 31227345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-CA-specific inhibitor dithiocarbamate Fc14-584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis.
    Aspatwar A; Hammarén M; Koskinen S; Luukinen B; Barker H; Carta F; Supuran CT; Parikka M; Parkkila S
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):832-840. PubMed ID: 28629306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel benzoic acid derivatives: Synthesis and biological evaluation as multitarget acetylcholinesterase and carbonic anhydrase inhibitors.
    Kalaycı M; Türkeş C; Arslan M; Demir Y; Beydemir Ş
    Arch Pharm (Weinheim); 2021 Mar; 354(3):e2000282. PubMed ID: 33155700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.